NCT05379985 2025-11-12Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASRevolution Medicines, Inc.Phase 1/2 Recruiting754 enrolled
NCT03093116 2025-07-10TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 2 FDA